US Patent 8183274 Treatment of hyperproliferative disorders with diarylhydantoin compounds
All edits
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+211 characters)
Article
Patent abstract
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Charles L. Sawyers0
Charlie D. Chen0
Chris Tran0
John Wongvipat0
Michael E. Jung0
Samedy Ouk0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08183274 Treatment of hyperproliferative disorders with diarylhydantoin compounds US Patent 8183274 Treatment of hyperproliferative disorders with diarylhydantoin compounds
Infobox
Patent Number
081832740
Patent Number
81832740
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
081832740
Date of Patent
May 22, 2012
0Patent Application Number
127085230
Date Filed
February 18, 2010
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 08183274 Treatment of hyperproliferative disorders with diarylhydantoin compounds
Infobox
Is a
Patent jurisdiction
Patent number
08183274
Date of patent
May 22, 2012
Patent application number
12708523
Date Filed
February 18, 2010
Patent primary examiner
Find more entities like US Patent 8183274 Treatment of hyperproliferative disorders with diarylhydantoin compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
